| Segment | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|
| North American Pharmaceutical | — | $852.00M | $1.06B |
| Oncology & Multispecialty | — | $332.00M | $304.00M |
| Medical-Surgical Solutions | $221.00M | $220.00M | $265.00M |
| Prescription Technology Solutions | $253.00M | $244.00M | $261.00M |
| Total | $253.00M | $244.00M | $261.00M |